Göğşen Önalan

ORCID: 0000-0003-3446-3751 · 14 papers in corpus
other 2026
Journal of the Turkish German Gynecological Association ·doi:10.4274/jtgga.galenos.2025.2025-10-5

We present a rare Müllerian anomaly known as "accessory cavitated uterine mass (ACUM)," which causes severe, refractory dysmenorrhea, and review the literature. A 17-year-old patient experienced severe, cyclic left-sided pelvic pain, correl…

2025
Journal of the Turkish German Gynecological Association ·doi:10.4274/jtgga.galenos.2025.2025-9-11

ObjectiveTo evaluate the oncological and reproductive outcomes of patients with ovarian sex-cord stromal tumors (SCSTs) treated with fertility sparing surgery (FSS).Material and methodsThis retrospective study included patients diagnosed wi…

article 2017
Gynecologic and obstetric investigation ·doi:10.1159/000484895

Aims: To determine the effects of a tumor necrosis factor inhibitor (etanercept) on pregnancy outcomes in patients with endometrioma who were treated with assisted reproductive technology. Methods: Sixty-eight infertile patients who had end…

article 2015
·doi:10.1016/j.fertnstert.2015.07.650
article 2013
Archives of gynecology and obstetrics ·doi:10.1007/s00404-013-2963-0

PurposeTo assess the effects of amifostine, N-acetyl cysteine (NAC), and leuprolide as a scavenger in a rat endometriosis model.MethodsThis is a prospective randomized animal study. Setting The Animal Laboratory of Medical University. Anima…

article 2009
Human Reproduction ·doi:10.1093/humrep/dep106

BACKGROUND: Doxycycline (Dox) has a number of non-antibiotic properties. One of them is the inhibition of matrix metalloproteinase (MMP) activity. The aim of this study was to assess the effects of Dox in a rat endometriosis model. METHODS:…

article 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.05.065

Fenofibrate -a peroxisome proliferator-activated receptor-a agonist- is an angiostatic agent that is commonly used in human liver diseases, therefore it may interfere with the angiogenetic process required for endometriosis. In a rat endome…

article 2008
·doi:10.1016/j.fertnstert.2008.07.1140
article 2007
·doi:10.1016/j.fertnstert.2007.07.707
article 2007
·doi:10.1016/j.fertnstert.2007.07.708
article 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.12.046

ObjectiveTo investigate the outcomes of intracytoplasmic sperm injection (ICSI) cycles after controlled ovarian hyperstimulation (COH) with GnRH antagonist or GnRH agonist (GnRH-a) in mild-to-moderate endometriosis and endometrioma.DesignPr…

article 2005
·doi:10.1016/j.fertnstert.2005.07.496
article 2005
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2005.08.002

ObjectiveTo determine follicular fluid (FF) and serum levels of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients undergoing IVF cycles.Study designA prospective comparative study among patients with endometriosis (n=12), infert…

article 2004
Fertility and Sterility ·doi:10.1016/j.fertnstert.2004.02.117

ObjectiveTo investigate whether aspiration of ovarian endometriomas before controlled ovarian stimulation (COH) improves intracytoplasmic sperm injection (ICSI) outcomes.DesignProspective study.SettingUniversity hospital.Patient(s)A prospec…